Jie Qiao

1PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 09, 2026
A phase II trial of chemotherapy-free neoadjuvant camrelizumab plus apatinib for resectable HNSCC: pathological response and vascular-immune crosstalk.

Pageof 1

Frequent Collaborators

1 joint publications

Yaqiong Jie

1 joint publications

Zhuo Chen

1 joint publications

Lihuang Chen

1 joint publications

Yushuo Zhang